Afrezza is the only inhaled, ultra rapid-acting mealtime insulin that delivers glucose management in the moment for adults living with type 1 or type 2 diabetes.
Insulin is a hormone stored in the pancreas that helps the body break down glucose (sugar) and turn it into energy. After a meal, insulin allows sugar to move from the bloodstream into cells to function properly. For those who have diabetes, the body either doesn’t make enough insulin (type 1) or doesn’t use insulin properly (type 2), making it difficult to regulate blood sugar levels while digesting food. This is where a rapid-acting or mealtime insulin like Afrezza comes in. Afrezza can be inhaled at the beginning of a meal to start lowering blood sugar levels in as little as 12 minutes without the use of injections.
Afrezza is designed to work differently from other mealtime insulins. Afrezza uses an insulin inhaler to quickly deliver rapid-acting insulin into the lungs and bloodstream via insulin powder. When Afrezza is taken at the beginning of a meal, it starts lowering blood sugar in as little as 12 minutes. And just as Afrezza enters the body quickly, it also leaves the body fast (within 1.5-3 hours, depending on dose*).
Technosphere technology, a platform that allows for lung delivery of medicines, is used to deliver Afrezza. The microparticle used in Afrezza consists of two main components: human insulin in its most basic form, combined with an inactive ingredient. These microparticles are inhaled deeply into the lungs, where they are quickly absorbed into the body. In fact, as Afrezza passes through the lungs, insulin is released into the bloodstream in less than 1 minute.
If you are struggling with blood sugar control at mealtime or prefer an injection-free mealtime insulin, it may be time to consider an alternative. Ask your doctor if Afrezza is right for you.
*For the 4-unit and 12-unit cartridges, respectively.
*Third-party website; does not constitute an endorsement or recommendation by MannKind Corporation.
US-AFR-1851
AFREZZA is a man-made insulin that is breathed-in through your lungs (inhaled) and is used to control high blood sugar in adults with diabetes mellitus.
What is the most important information I should know about AFREZZA? AFREZZA can cause serious side effects, including:
Sudden lung problems (bronchospasms). In a study, some AFREZZA-treated patients with asthma, whose asthma medication was temporarily withheld, experienced sudden lung problems. Do not use AFREZZA if you have long-term (chronic) lung problems such as asthma or chronic obstructive pulmonary disease (COPD). Before starting AFREZZA, your healthcare provider will give you a breathing test to check how your lungs are working.
Do not use Afrezza® if you:
Before using Afrezza®, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins or herbal supplements.
Before you start using Afrezza®, talk to your healthcare provider about low blood sugar and how to manage it.
While using Afrezza® do not:
Afrezza® may cause serious side effects that can lead to death, including:
See “What is the most important information I should know about Afrezza®?”
Treatment with TZDs and Afrezza® may need to be changed or stopped by your healthcare provider if you have new or worse heart failure.
Get emergency medical help if you have:
• Trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, confusion.
The most common side effects of Afrezza® include:
These are not all the possible side effects of Afrezza®. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088 (1-800-332-1088).
Please See Full Prescribing Information, including BOXED WARNING, Medication Guide and Instructions for Use for AFREZZA.
AFREZZA, the Afrezza logo, AFREZZAASSIST, AFREZZAASSIST and logo, MANNKIND, and BLUHALE VIS are registered trademarks of MannKind Corporation. © 2024 MannKind Corporation.
This site is intended for use by U.S. residents only.
Complete a quick medical questionnaire to help determine if Afrezza is right for you.
Schedule an appointment with a licensed healthcare provider.
If Afrezza is right for you, pick it up from your local pharmacy or have it delivered to your home.
You are now leaving Afrezza.com
By clicking “Yes” below, you acknowledge and agree that MannKind does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. MannKind makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. MannKind recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. MANNKIND AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE.
If you agree to the above, click “YES” to proceed to the third-party website. If you do not agree to the above, click “NO” to remain on Afrezza.com.